OR1-2 | Comparing Outcomes of Endovascular Revascularization for Chronic Limb-threatening Ischemia in Medicare Advantage and Medicare Fee-for-service Beneficiaries
Enrollment in Medicare Advantage (MA), a private alternative to Medicare Fee-for-Service (FFS), is projected to surpass FFS. The transportability of peripheral arterial disease (PAD) outcomes studies in the FFS population to MA is unknown. We compared endovascular revascularization outcomes for chronic limb-threatening ischemia (CLTI) between MA and FFS beneficiaries.
Authors
- Siling Li (ORCID: https://orcid.org/0009-0006-7645-0878)
- Rishi K. Wadhera (ORCID: https://orcid.org/0000-0003-1089-3896)
- Yang Song (ORCID: https://orcid.org/0000-0002-6248-8086)
- Eric A. Secemsky (ORCID: https://orcid.org/0000-0003-3861-3163)
- Robert W. Yeh (ORCID: https://orcid.org/0000-0002-0564-4468)
- Joseph M. Kim (ORCID: https://orcid.org/0000-0003-1584-3927)
- Katerina Dangas
Institutions
- Mount Sinai Beth Israel (US)
- Beth Israel Deaconess Medical Center (US)
- Beth Israel Deaconess Hospital (US)
Publication Details
- Journal
- Journal of the Society for Cardiovascular Angiography & Interventions
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1016/j.jscai.2025.102653
- Primary Topic
- Peripheral Artery Disease Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00